Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -198,471 | -141,985 | -79,151 | -23,198 | -117,732 |
| Depreciation Amortization | 6,481 | 4,520 | 2,880 | 1,372 | 3,881 |
| Income taxes - deferred | 1,346 | N/A | N/A | N/A | N/A |
| Accounts receivable | 3,339 | 43 | 372 | 1,411 | -1,733 |
| Accounts payable and accrued liabilities | 3,501 | 1,668 | 3,755 | -293 | 4,215 |
| Other Working Capital | 187,120 | 195,004 | 194,983 | -6,290 | 4,906 |
| Other Operating Activity | 35,246 | 30,535 | 15,976 | 7,989 | 29,514 |
| Operating Cash Flow | $38,562 | $89,785 | $138,815 | $-19,009 | $-76,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,915 | -8,693 | -5,267 | -2,533 | -20,164 |
| Purchase Of Investment | -506,067 | -367,587 | -226,289 | -211,163 | -353,177 |
| Sale Of Investment | 396,632 | 334,448 | 252,468 | 198,868 | 501,650 |
| Investing Cash Flow | $-119,350 | $-41,832 | $20,912 | $-14,828 | $128,309 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 170,008 | 165,909 | 2,557 | 1,108 | 6,580 |
| Other Financing Activity | -230 | -124 | 0 | 0 | -207 |
| Financing Cash Flow | $169,778 | $165,785 | $2,557 | $1,108 | $6,373 |
| Beginning Cash Position | 71,764 | 71,764 | 71,764 | 71,764 | 14,031 |
| End Cash Position | 160,754 | 285,502 | 234,048 | 39,035 | 71,764 |
| Net Cash Flow | $88,990 | $213,738 | $162,284 | $-32,729 | $57,733 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,562 | 89,785 | 138,815 | -19,009 | -76,949 |
| Capital Expenditure | -9,915 | -8,693 | -5,267 | -2,533 | -20,164 |
| Free Cash Flow | 28,647 | 81,092 | 133,548 | -21,542 | -97,113 |